REPLIMUNE GROUP, INC.

REPL ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $461.2M

Liabilities Breakdown FY2022

Total Liabilities: $50.0M